Ramelteon: A melatonin receptor agonist for the treatment of insomnia

V. Devi, P. Shankar

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for the treatment of insomnia characterized by difficulty in sleep onset. It is a nonscheduled drug since it lacks the potential for abuse and does not interact with neurotransmitter receptors most associated with these phenomena. Although the effects of ramelteon use >5 weeks are unknown, the available data confirms its safety and efficacy for short-term use. Clinical use and future research should uncover more information about ramelteon's properties.

Original languageEnglish
Pages (from-to)45-48
Number of pages4
JournalJournal of Postgraduate Medicine
Volume54
Issue number1
Publication statusPublished - 01-01-2008

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Fingerprint Dive into the research topics of 'Ramelteon: A melatonin receptor agonist for the treatment of insomnia'. Together they form a unique fingerprint.

  • Cite this